Evaluating the Role of BglI rs739837 and TaqI rs731236 Polymorphisms in Vitamin D Receptor with SARS-CoV-2 Variants Mortality Rate
- PMID: 36553614
- PMCID: PMC9777972
- DOI: 10.3390/genes13122346
Evaluating the Role of BglI rs739837 and TaqI rs731236 Polymorphisms in Vitamin D Receptor with SARS-CoV-2 Variants Mortality Rate
Abstract
A lack of vitamin D is a potential risk factor for coronavirus disease (COVID-19). Variants in the Vitamin D Receptor (VDR) gene, such as BglI rs739837 and TaqI rs731236, are associated with various viral infection progressions. This study aimed to evaluate the relationship between the BglI rs739837 and TaqI rs731236 polymorphisms and the mortality rate of COVID-19 based on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The genotyping of BglI rs739837 and TaqI rs731236 genotypes was analyzed using the polymerase chain reaction-restriction fragment length polymorphism in 1734 improved and 1450 deceased patients positive for SARS-CoV-2. In this study, the rate of COVID-19 mortality was correlated with TaqI rs731236 TC and CC in the α variant and with TaqI rs731236 CC in the Delta variant, whereas no relationship was found in the Omicron BA.5 variant. In addition, the rate of COVID-19 mortality was associated with BglI rs739837 GT and TT in the Omicron BA.5 variant, while there was no association between BglI rs739837 and COVID-19 mortality in the α and Delta variants. The TG haplotype was more common in all SARS-CoV-2 variants, while the CT haplotype was associated with COVID-19 mortality in the Delta and Omicron BA.5 variants. In conclusion, this study indicated that the impacts of BglI rs739837 and TaqI rs731236 polymorphisms were related to SARS-CoV-2 variants. However, further research is still needed to approve our findings.
Keywords: Vitamin D receptor; coronavirus disease 2019; severe acute respiratory syndrome coronavirus 2 variants.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.Hum Genomics. 2023 Jun 16;17(1):54. doi: 10.1186/s40246-023-00501-8. Hum Genomics. 2023. PMID: 37328914 Free PMC article.
-
Relationship between CDX2 rs11568820 and EcoRV rs4516035 polymorphisms on the vitamin D receptor gene with susceptibility to different SARS-CoV-2 variants.Cell Biol Int. 2023 Oct;47(10):1728-1736. doi: 10.1002/cbin.12064. Epub 2023 Jun 27. Cell Biol Int. 2023. PMID: 37369952
-
Association of vitamin D receptor gene polymorphisms with caries risk in children: a systematic review and meta-analysis.BMC Pediatr. 2024 Oct 11;24(1):650. doi: 10.1186/s12887-024-05127-w. BMC Pediatr. 2024. PMID: 39394075 Free PMC article.
-
Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants.Hum Genomics. 2023 Mar 7;17(1):19. doi: 10.1186/s40246-023-00468-6. Hum Genomics. 2023. PMID: 36882862 Free PMC article.
-
The Most Common Vitamin D Receptor Polymorphisms (ApaI,FokI, TaqI, BsmI, and BglI) in Children with Dental Caries: A Systematic Review and Meta-Analysis.Children (Basel). 2021 Apr 15;8(4):302. doi: 10.3390/children8040302. Children (Basel). 2021. PMID: 33920959 Free PMC article. Review.
Cited by
-
Genetic Variations of the Vitamin D Metabolic Pathway and COVID-19 Susceptibility and Severity: Current Understanding and Existing Evidence.Biomedicines. 2023 Jan 29;11(2):400. doi: 10.3390/biomedicines11020400. Biomedicines. 2023. PMID: 36830936 Free PMC article. Review.
-
The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.Hum Genomics. 2023 Jun 16;17(1):54. doi: 10.1186/s40246-023-00501-8. Hum Genomics. 2023. PMID: 37328914 Free PMC article.
-
The Association of Vitamin D Receptor Polymorphisms with COVID-19 Severity.Nutrients. 2024 Mar 2;16(5):727. doi: 10.3390/nu16050727. Nutrients. 2024. PMID: 38474855 Free PMC article.
-
Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.Inflammopharmacology. 2024 Feb;32(1):249-271. doi: 10.1007/s10787-023-01383-x. Epub 2023 Nov 13. Inflammopharmacology. 2024. PMID: 37957515 Free PMC article. Review.
-
Role of FokI rs2228570 and Tru9I rs757343 Polymorphisms in the Mortality of Patients Infected with Different Variants of SARS-CoV-2.Arch Med Res. 2023 Jun;54(4):310-318. doi: 10.1016/j.arcmed.2023.03.006. Epub 2023 Mar 31. Arch Med Res. 2023. PMID: 37032232 Free PMC article.
References
-
- Carpagnano G.E., Di Lecce V., Quaranta V.N., Zito A., Buonamico E., Capozza E., Palumbo A., Di Gioia G., Valerio V.N., Resta O. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J. Endocrinol. Investig. 2021;44:765–771. doi: 10.1007/s40618-020-01370-x. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous